MOQC Gynecology Oncology Kickoff Meeting

MOQC’s Gynecological Oncology (Gyn-Onc) initiative aims to improve the timeliness of treatment and quality of care in patients with gynecologic cancers within the state of Michigan.

Gynecological cancers include the cancers of the cervix, endometrium, ovary, uterus, or vulva. Of these malignancies, ovarian cancer is the most lethal.  Although it accounts only for 3% of all cancers in women, each year in the United States, about 21,000 women get ovarian cancer and about 14,000 die from it. However, when found in its early stages, the likelihood of cure is high1.

In 2014, (the most recent year numbers are available), 21,161 women in the United States were diagnosed with ovarian cancer, and 14,195 women in the United States died from it.2

Ovarian cancer treatment has several phases. Most patients require a combination of surgery and chemotherapy as a part of initial treatment. This requires a multidisciplinary team involving gynecologic oncologists, surgeons, and medical oncologists.

MOQC’s goal is to look for and identify gaps in care received by patients with ovarian cancer, and to use this information to find strategies and employ methods that will help improve the timeliness, delivery, quality of care, and quality of life in patients with ovarian cancer in the state of Michigan. Over time we intend to expand to other gynecological cancers with innovative ideas like implementation of enhanced recovery protocols after surgery, implementation of sentinel lymph node dissection in endometrial cancer and improved workflow to reduce intense care at the end of life.

The ASCO QOPI platform will be used to abstract data to find and measure the gap in care in patients undergoing surgery and receiving chemotherapy. Gyn-Onc Surgeons from hospitals and practices across the state are participating in this initiative. Data collection is projected to start in Spring 2018.

If your hospital/practice, surgeon or oncologist is interested in receiving additional information about this initiative or would like to join, please contact Arthi Ramakrishnan or 734-764-2829.

Shitanshu Uppal, MBBS
Co-Director, MOQC

Arthi Ramakrishnan, MS, CCRP
Senior Project Manager


Improved Survival Associated with Early Initiation of Chemotherapy After Complete Resection of Advanced Ovarian CA

Chemotherapy Delay after Primary Debulking Surgery for Ovarian CA

2 Data source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2017. Available at: